-
September 28: The Week in Cancer News
A study characterizes “chemo brain” in breast cancer patients treated with chemotherapy, and physicians and scientists gather in Toronto to present their lung cancer research.
by Kate Yandell
-
Sacrificing for Care
A study finds that patients with cancer not only say they are willing to make financial sacrifices for treatment but actually have done so.
by Marilyn Fenichel
-
The Genetics of Metastatic Cancer
The multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.
by Anna Azvolinsky
-
A Sense of Purpose
In a Facebook Live discussion about When Breath Becomes Air, Lucy Kalanithi talks about safeguarding a person’s identity in the face of terminal disease and shares tips and resources for caregiving.
by Marci A. Landsmann
-
September 21: The Week in Cancer News
Patients weigh in on the impact of end-of-treatment bells in cancer centers, and a study suggests that current protocols for BRCA screening may miss testing some patients with mutations.
by Kate Yandell
-
September 14: The Week in Cancer News
An article sparks discussion about precision medicine hype, and a study tallies the rare fatal side effects of immune checkpoint inhibitors.
by Kate Yandell
-
The Roots of Rural Health Disparities
New research shows that rural cancer patients have the same health outcomes as urban cancer patients so long as they are involved in a clinical trial.
by Cheryl Platzman Weinstock
-
Learning to Share
At first, I wanted to hide my cancer diagnosis. My son showed me what a mistake that was.
by Lenn Robbins
-
The Health Legacy of 9/11
People who were directly affected by the Sept. 11 terrorist attacks can receive screenings and care for medical conditions, including certain cancers, through the World Trade Center Health Program.
by Brad Jones
-
September 7: The Week in Cancer News
A study quantifies gains in breast cancer survival in young women, and a cancer doctor reflects on her experience as a cancer patient.
by Kate Yandell
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona